Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

601 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens.
Pezzullo L, Giudice V, Serio B, Fontana R, Guariglia R, Martorelli MC, Ferrara I, Mettivier L, Bruno A, Bianco R, Vaccaro E, Pagliano P, Montuori N, Filippelli A, Selleri C. Pezzullo L, et al. Among authors: bianco r. Open Med (Wars). 2021 Apr 21;16(1):672-682. doi: 10.1515/med-2021-0274. eCollection 2021. Open Med (Wars). 2021. PMID: 33981851 Free PMC article.
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience.
De Novellis D, Fontana R, Palmieri S, Della Pepa R, Di Perna M, Cetani G, Esposito D, Amendola A, Delle Cave G, Serio B, Morini D, Rizzo M, Mettivier L, Trastulli F, Rocco S, Pagano A, Barbato S, Leone A, La Magna M, Bianco R, Rascato G, Carobene A, Cuffa B, Iannalfo M, Giudice V, Svanera G, Annunziata M, Pizzuti M, Frigeri F, Califano C, Ferrara F, Pane F, Selleri C. De Novellis D, et al. Among authors: bianco r. Target Oncol. 2023 Nov;18(6):885-892. doi: 10.1007/s11523-023-01001-4. Epub 2023 Sep 25. Target Oncol. 2023. PMID: 37747623 Free PMC article.
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.
De Novellis D, Derudas D, Vincelli D, Fontana R, Della Pepa R, Palmieri S, Accardi F, Rotondo F, Morelli E, Gigliotta E, Roccotelli D, Marano L, Barone ML, Cetani G, Esposito D, Lazzaro A, Delle Cave G, Serio B, Morini D, Porrazzo M, Urciuoli E, Masucci C, Fanelli F, Rizzo M, Arcamone M, Trastulli F, Rocco S, Leone A, Bianco R, Salvatore F, Idato A, Sicari M, Tosi P, Rascato MG, Di Perna M, Falcone AP, Morello L, Carlisi M, Svanera G, Annunziata M, Frigeri F, Califano C, Carella AM, Marcacci G, Pane F, Risitano AM, Giudice V, Botta C, Selleri C. De Novellis D, et al. Among authors: bianco r. Eur J Haematol. 2025 Jan;114(1):105-114. doi: 10.1111/ejh.14314. Epub 2024 Oct 6. Eur J Haematol. 2025. PMID: 39370303 Free PMC article.
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.
Martino EA, Derudas D, Rossi E, Terlizzi S, Reddiconto G, Stefanoni P, Micozzi J, Mangiacavalli S, Zamagni E, Offidani M, Furlan A, Buda G, Lotti F, Liberatore C, Lazzaro A, Della Pepa R, Bertuglia G, Barbieri E, Conticello C, De Magistris C, De Paoli L, Bongarzoni V, Cafro AM, Mele A, Benvenuti P, Cerchione C, Botta C, Antonioli E, Sgherza N, Aquino S, Mele G, Barilà G, Palmieri S, Annibali O, Bianco R, Febbo MA, Casaluci GM, Rago A, Fontana R, Farina F, Vigna E, Bruzzese A, Mancuso K, Nappi D, Morè S, Rivolti E, Califano C, Amendola A, Roccotelli D, Lombardo A, Citro A, Uccello G, Zambello R, Maggi A, Neri S, Monachesi M, Gozzetti A, Montefusco V, Brunori M, Cotzia E, Pietrantuono G, Quinto AM, Amico V, Di Renzo N, Coscia M, Galli M, De Stefano V, Petrucci MT, Neri A, Di Raimondo F, Morabito F, Musto P, Gentile M. Martino EA, et al. Among authors: bianco r. Haematologica. 2024 Nov 28. doi: 10.3324/haematol.2024.286658. Online ahead of print. Haematologica. 2024. PMID: 39605207 Free article.
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.
Morè S, Federici I, Bossi A, Rupoli S, Morsia E, Manieri VM, Olivieri A, Petrucci MT, Fazio F, Lisi C, Sorella S, Paoli AD, Farina F, Mele A, De Francesco R, Greco A, Fioritoni F, Liberatore C, De Toritto TC, Tordi A, Siniscalchi A, Brunori M, Sgherza N, Musto P, Amendola A, Vacca A, Solimando AG, Melaccio A, Palma A, Melillo LMA, Ciuffreda L, Gentili S, Buda G, Del Giudice ML, Falcone AP, Tosi P, Tomassetti S, Rotondo F, Gozzetti A, Galieni P, Ruggieri M, Frigeri F, Bianco R, Lombardo A, Trastulli F, Corvatta L, Zizzo C, Duro G, Offidani M. Morè S, et al. Among authors: bianco r. Hemasphere. 2025 Jan 22;9(1):e70079. doi: 10.1002/hem3.70079. eCollection 2025 Jan. Hemasphere. 2025. PMID: 39850649 Free PMC article. No abstract available.
Neural encoding of musical expectations in a non-human primate.
Bianco R, Zuk NJ, Bigand F, Quarta E, Grasso S, Arnese F, Ravignani A, Battaglia-Mayer A, Novembre G. Bianco R, et al. Curr Biol. 2025 Jan 14:S0960-9822(25)00015-6. doi: 10.1016/j.cub.2025.01.015. Online ahead of print. Curr Biol. 2025. PMID: 39814027 Free article. No abstract available.
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma.
Esposito D, Napolitano F, Maresca DC, Scala M, Amato A, Belli S, Ascione CM, Vallefuoco A, Attanasio G, Somma F, Ianaro A, Russo D, Varricchio S, Mascolo M, Costa C, Villani A, Scalvenzi M, Orlandino G, Troiani T, Servetto A, Bianco R, Ercolano G, Formisano L. Esposito D, et al. Among authors: bianco r. J Immunother Cancer. 2025 Jan 11;13(1):e010421. doi: 10.1136/jitc-2024-010421. J Immunother Cancer. 2025. PMID: 39800379 Free PMC article.
601 results